New Ray of Hope for Psychosis in Parkinsons:Pimavanserin

N. Grewal
2016 International Journal of Medical and Dental Sciences  
Parkinson's disease is often associated with hallucinations and psychosis. Till now typical and atypical antipsychotics (Clozapine & Quetiapine) are being used to manage these symptoms. Recently US FDA has approved a new drug Pimavanserin for the treatment of hallucination and delusion associated with parkinson's disease psychosis in a dose of 34 mg.
doi:10.19056/ijmdsjssmes/2016/v5i2/100633 fatcat:r3vuvmhatzdmrb3u7pmoxue7qe